当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Lemmy Ojang Owan, Hamza Ibrahim
This article encompasses a review of the limitations of the current methods used for the detection of SARS CoV-2 (the virus responsible for COVID-19) at airports across the globe. These methods involve the screening for vital signs and symptoms, including thermal scanning, heart rate and breathing capabilities. From the impact of COVID-19, other pathogens could be exploited as potential weapons (bioweapons) against civil aviation. Bioagents such as viruses, bacteria, fungi, and toxins, have been used by the military and terrorists in conflicts to cause mass casualties, death, panic, and disruptions. In this review, focus is on the development of biosensor detection system that will address the limitations of the current measures being employed to detect pathogens. Biosensor detection system offers real-time, specific, sensitive, and a cost-effective means of detection of bioweapons at airports.